Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2014 | 03-2013 | 03-2012 | 12-2011 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | N/A | N/A | N/A | 119,970 |
| Marketable Securities | N/A | N/A | N/A | N/A | 3,680 |
| Receivables | N/A | N/A | N/A | N/A | 134,570 |
| Inventories | N/A | N/A | N/A | N/A | 86,020 |
| Other current assets | 0 | 0 | 0 | 0 | 480 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $344,720 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 161,670 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 91,180 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $252,850 |
| Total Assets | $N/A | $N/A | $N/A | $N/A | $597,580 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 13,590 |
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 0 | 103,530 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $134,440 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 32,080 |
| Other Non-Current Liabilities | -472 | 0 | 0 | 0 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $42,570 |
| Total Liabilities | $N/A | $N/A | $N/A | $N/A | $177,010 |
| Shareholders' Equity | |||||
| Other shareholders' equity | 0 | 0 | 0 | 0 | 420,560 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $420,560 |
| Total Liabilities And Equity | $0 | $0 | $0 | $0 | $597,570 |